348 related articles for article (PubMed ID: 20552297)
1. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
2. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
3. Neutral sphingomyelinases and nSMase2: bridging the gaps.
Clarke CJ; Hannun YA
Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
[TBL] [Abstract][Full Text] [Related]
5. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
[TBL] [Abstract][Full Text] [Related]
6. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
Shamseddine AA; Airola MV; Hannun YA
Adv Biol Regul; 2015 Jan; 57():24-41. PubMed ID: 25465297
[TBL] [Abstract][Full Text] [Related]
7. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
8. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
Yabu T; Imamura S; Yamashita M; Okazaki T
J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
[TBL] [Abstract][Full Text] [Related]
9. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.
Zager RA; Conrad S; Lochhead K; Sweeney EA; Igarashi Y; Burkhart KM
Kidney Int; 1998 Mar; 53(3):573-82. PubMed ID: 9507201
[TBL] [Abstract][Full Text] [Related]
10. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
11. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N; Luberto C; Hannun YA
J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
[TBL] [Abstract][Full Text] [Related]
13. Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide.
Lin M; Liao W; Dong M; Zhu R; Xiao J; Sun T; Chen Z; Wu B; Jin J
FEBS J; 2018 Oct; 285(20):3835-3848. PubMed ID: 30106227
[TBL] [Abstract][Full Text] [Related]
14. Signalling sphingomyelinases: which, where, how and why?
Levade T; Jaffrézou JP
Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
[TBL] [Abstract][Full Text] [Related]
15. The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation.
Zeidan YH; Hannun YA
Curr Mol Med; 2010 Jul; 10(5):454-66. PubMed ID: 20540705
[TBL] [Abstract][Full Text] [Related]
16. Sphingomyelinases and Liver Diseases.
Insausti-Urkia N; Solsona-Vilarrasa E; Garcia-Ruiz C; Fernandez-Checa JC
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143193
[TBL] [Abstract][Full Text] [Related]
17. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.
Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J
J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266
[TBL] [Abstract][Full Text] [Related]
18. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
19. Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.
Matmati N; Hannun YA
J Lipid Res; 2008 May; 49(5):922-8. PubMed ID: 18305313
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling.
Yabu T; Shiba H; Shibasaki Y; Nakanishi T; Imamura S; Touhata K; Yamashita M
Cell Death Differ; 2015 Feb; 22(2):258-73. PubMed ID: 25168245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]